Company & Sponsor Intelligence
Thomas Jefferson University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed1
Countries1
Therapeutic footprint
depression
Indexed studies
NCT02454426Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease
depression · United StatesEARLY_PHASE1
depression · United StatesEARLY_PHASE1
NCT00269633Research Study of Treatment for Winter Depression With Different Colors of Light
depression · United StatesPHASE2
depression · United StatesPHASE2
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →